Trade MRVI anytime, even after market hours
Regulated by
MAS
Trusted by
400,000+ users
Maravai LifeSciences Holdings, Inc. Class A (MRVI) is trading at US$7.22, down 1.43% today as of Sep 8, 12:13 EDT. The company has a market capitalisation of US$1.29B. Over the past 52 weeks, MRVI has traded between US$2.42 and US$9.42. On Syfe you can trade MRVI with $0 commission and add it to your watchlist.
| Previous close | US$7.32 |
|---|---|
| Market cap | US$1.29B |
| 52-week range | US$2.42 – US$9.42 |
| Volume | 1.55M |
| Exchange | US |
Add to Watchlist
Set Price Alert
Maravai LifeSciences Holdings, Inc. Class A
Maravai Lifesciences Holdings, Inc. engages in providing products to enable the development of drug therapies, diagnostics, and novel vaccines and to support research on human diseases. The firm’s brands include TriLink BioTechnologies, Cygnus, Glen Research, and Alphazyme. It operates through the TriLink and Cygnus segments. The TriLink segment manufactures and sells products used in the fields of gene therapy, vaccines, nucleoside chemistry, oligonucleotide therapy and molecular diagnostics, including reagents used in the chemical synthesis, modification, labelling, and purification of deoxyribonucleic acid (DNA) and ribonucleic acid (RNA). The Cygnus segment sells biologic safety testing products and highly specialized analytical products for use in biologic manufacturing process development, including custom product-specific antibody and assay development services. It also operates through the following geographical segments: North America, Asia Pacific, Europe, the Middle East, and Africa, and Latin and Central America. The company was founded by Eric Tardif and Carl W. Hull in March 2014 and is headquartered in San Diego, CA.
Year: 2020
Deutsche Bank Adjusts Maravai Lifesciences PT to $8 From $6, Maintains Buy Rating
Aug 7, 12:58 PM · MT Newswires
-- Earnings Flash (MRVI) Maravai LifeSciences Holdings, Inc. Posts Q2 Adjusted Loss $0.02 per Share, vs. FactSet Est of $-0.04
Aug 6, 8:14 PM · MT Newswires
-- Earnings Flash (MRVI) Maravai LifeSciences Holdings, Inc. Reports Q2 Revenue $51.4M, vs. FactSet Est of $48.7M
Aug 6, 8:13 PM · MT Newswires
Maravai LifeSciences Holdings, Inc. Class A (MRVI) stock is trading at US$7.22, -1.43% from the previous close of US$7.32.
The market cap for Maravai LifeSciences Holdings, Inc. Class A (MRVI) stock is approximately US$1.29B.
The 52-week high for Maravai LifeSciences Holdings, Inc. Class A (MRVI) stock is US$9.42.
The 52-week low for Maravai LifeSciences Holdings, Inc. Class A (MRVI) stock is US$2.42.
Maravai LifeSciences Holdings, Inc. Class A (MRVI) does not currently pay a dividend.
Stay on top of MRVI
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
